Amicus Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FOLD and other ETFs, options, and stocks.

About FOLD

Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases.

CEO

Bradley Lewis Campbell

CEOBradley Lewis Campbell

Employees

517

Employees517

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

2002

Founded2002

Employees

517

Employees517

FOLD Key Statistics

Market cap

3.04B

Market cap3.04B

Price-Earnings ratio

-19.65

Price-Earnings ratio-19.65

Dividend yield

—

Dividend yield—

Average volume

3.10M

Average volume3.10M

High today

$10.32

High today$10.32

Low today

$10.11

Low today$10.11

Open price

$10.26

Open price$10.26

Volume

1.71M

Volume1.71M

52 Week high

$14.57

52 Week high$14.57

52 Week low

$9.70

52 Week low$9.70

FOLD News

Simply Wall St 4d

When Will Amicus Therapeutics, Inc. Become Profitable? - Simply Wall St

With the business potentially at an important milestone, we thought we'd take a closer look at Amicus Therapeutics, Inc.'s ( ) future prospects. Amicus Therapeu...

Analyst ratings

73%

of 11 ratings

Buy

72.7%

Hold

27.3%

Sell